Rhumatologie. La goutte. [Gout]

Details

Serval ID
serval:BIB_8D2784EFA8A2
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Rhumatologie. La goutte. [Gout]
Journal
Revue Médicale Suisse
Author(s)
Carey Berner  I., Dudler  J.
ISSN
1660-9379 (Print)
Publication state
Published
Issued date
01/2006
Volume
2
Number
48
Pages
160-2
Notes
English Abstract
Journal Article
Review --- Old month value: Jan 11
Abstract
Gout must be regarded as a systemic and chronic disease with potentially serious sequelae. Hyperuricemia is probably an independent risk factor for cardiovascular diseases, at least in high-risk individuals. Nevertheless, current data do not justify for the moment the treatment of asymptomatic hyperuricemia. Finally, if allopurinol remains the only available agent in Switzerland for the treatment of chronic gout, new molecules, like febuxostat and pegylated uricase, are currently being evaluated.
Keywords
Acute Disease Cardiovascular Diseases/etiology/prevention & control Chronic Disease Gout/*drug therapy/etiology Humans Hyperuricemia/complications/*drug therapy Risk Factors
Pubmed
Create date
25/01/2008 8:31
Last modification date
20/08/2019 14:51
Usage data